| Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
|---|
| 01/03/2002 | WO2002000342A2 Method and apparatus for performing an assay |
| 01/03/2002 | WO2002000336A2 Composite arrays utilizing microspheres with a hybridization chamber |
| 01/03/2002 | WO2002000262A2 Modulation of chromosome function by chromatin remodeling agents |
| 01/03/2002 | WO2002000250A2 Hiv-1 vaccines and screening methods therefor |
| 01/03/2002 | WO2002000245A1 Neurotoxic oligomers |
| 01/03/2002 | WO2002000232A2 Methods and compositions for developing spore display systems for medicinal and industrial applications |
| 01/03/2002 | WO2002000112A2 Glucose metering system |
| 01/03/2002 | WO2002000005A1 Libraries displaying human antibody fragments with hybrid complementarity determining regions |
| 01/03/2002 | WO2001073426A3 Blood transfusion method and device |
| 01/03/2002 | WO2001073125A3 High throughput screening array containing porous material |
| 01/03/2002 | WO2001071005A3 Multifunctional polypeptides comprising a binding site to an epitope of the nkg2d receptor complex |
| 01/03/2002 | WO2001069248A3 An immunoassay diagnostic probe and its use |
| 01/03/2002 | WO2001066708A3 MATERIALS AND METHODS RELATING TO THE DEGRADATION OF Cdc25A IN RESPONSE TO DNA DAMAGE |
| 01/03/2002 | WO2001065211A3 Method for operating a sensor |
| 01/03/2002 | WO2001055336A3 Methods and materials relating to cd84-like polypeptides and polynucleotides |
| 01/03/2002 | WO2001053344A3 Chondromodulin-i related peptide |
| 01/03/2002 | WO2001046696A3 Methods and compositions for detecting hepatitis e virus |
| 01/03/2002 | WO2001046383A3 Compositions and methods involving an essential staphylococcus aureus gene and its encoded protein |
| 01/03/2002 | WO2001045494A3 Pyrophosphatase stress-related proteins and methods of use in plants |
| 01/03/2002 | WO2001044508A3 Method to evaluate the sensitivity of hiv variants to drugs able to inhibit the hiv protease |
| 01/03/2002 | WO2001041813A3 Methods of treating lupus based on antibody affinity and screening methods and compositions for use thereof |
| 01/03/2002 | WO2001037719A3 Prognostic testing of organs intended for transplantation |
| 01/03/2002 | WO2001036972A3 Elisa for vegf |
| 01/03/2002 | WO2001035100A3 Binding acceleration techniques for the detection of analytes |
| 01/03/2002 | WO2001032877A3 CpG RECEPTOR (CpG-R) AND METHODS RELATING THERETO |
| 01/03/2002 | WO2001028587A3 Magnetic targeted carrier |
| 01/03/2002 | WO2001028532A3 Methods and compositions for predicting, diagnosing and treating lipodystrophy |
| 01/03/2002 | WO2001024826A3 Inrease of enos activity through activation of the pi3-kinase/akt pathway by estrogens |
| 01/03/2002 | WO2000066783A3 Rapid and efficient capture of dna from sample without using cell lysing reagent |
| 01/03/2002 | WO2000063429A3 Automatable rapid test for detecting cancers, on the basis of telomerase(htc) mrna and specific primers and probes |
| 01/03/2002 | WO2000056926A3 Methods for detection of nucleic acid polymorphisms using peptide-labeled oligonucleotides and antibody arrays |
| 01/03/2002 | WO2000055358A9 4-(4-hydroxystyryl)pyridine-containing substrates for an analyte dependent enzyme activation system |
| 01/03/2002 | WO1999058948A3 Enumeration method of analyte detection |
| 01/03/2002 | WO1999031959A3 Accelerated stability test for granulated protein |
| 01/03/2002 | US20020002343 Devices, methods and systems for collecting material from a breast duct |
| 01/03/2002 | US20020002273 Rapamycin assay |
| 01/03/2002 | US20020002270 Purified antigen for alzheimer's disease, and methods of obtaining and using same |
| 01/03/2002 | US20020002142 Method for identifying and using A2B adenosine receptor antagonists to mediate mammalian cell proliferation |
| 01/03/2002 | US20020002134 PAI-2 conjugates for the treatment and imaging of cancer |
| 01/03/2002 | US20020001855 Methods and apparatus for parallel magnetic biological analysis and manipulation |
| 01/03/2002 | US20020001854 Apparatus for determining stability of sample; for use in drug screening |
| 01/03/2002 | US20020001853 Detection of very low quantities of analyte bound to a solid phase |
| 01/03/2002 | US20020001852 Solid phase apparatus for use colorimetric chemical analysis |
| 01/03/2002 | US20020001851 Apparatus for absorbance-based chemical analysis |
| 01/03/2002 | US20020001846 Preparation of blood samples for detecting homocysteine and/or folate |
| 01/03/2002 | US20020001845 Polymer brushes for immobilizing molecules to a surface and having water-soluble or water-dispersible segments therein and probes bonded thereto |
| 01/03/2002 | US20020001839 Device for use in hybridization and binding analysis; for use in drug screening and sequencing nucleic acids; for use as tool in genetic analysis |
| 01/03/2002 | US20020001824 Ligand-gated anion channels of insects |
| 01/03/2002 | US20020001822 Apparatus and methods for chemiluminescent assays |
| 01/03/2002 | US20020001820 Method for detecting bacterial exacerbations of chronic lung disease |
| 01/03/2002 | US20020001818 Device for carrying out lateral-flow assays involving more than one analyte |
| 01/03/2002 | US20020001817 Assay for specific strains of multiple disease related conformations of a protein |
| 01/03/2002 | US20020001815 Methods for screening compound libraries |
| 01/03/2002 | US20020001814 Automatic process |
| 01/03/2002 | US20020001812 Mixed-bed solid phase and its use in the isolation of nucleic acids |
| 01/03/2002 | US20020001811 Isolating preferential nucleotide sequences from sample; incubate sample with solid support, elute, recover preferential sequences |
| 01/03/2002 | US20020001804 Genomic analysis of tRNA gene sets |
| 01/03/2002 | US20020001803 Detecting preferential particles in sample; mix fluid, expose to centrifugal force, while rotating, recover reaction products |
| 01/03/2002 | US20020001797 Method for detecting endocrine disrupting action of a test substance |
| 01/03/2002 | US20020001796 Novel enzymatic approach for analytical method development |
| 01/03/2002 | US20020001597 Eliciting in vertebrate a protective immune response against bacterium of the genus Chlamydia; carrier group coupled to oligosaccharide |
| 01/03/2002 | US20020001586 Inhibiting proliferation of neural cells via contacting with antibody, antisense nucleotide, and/or polynucleotide that disrupts activity of granulin molecule |
| 01/03/2002 | US20020001543 Transport device for analysing hydrocarbon-containing constituents |
| 01/03/2002 | US20020001539 Apparatus and methods for chemiluminescent assays |
| 01/03/2002 | US20020001402 System and method for generating a profile of particulate components of a body fluid sample |
| 01/03/2002 | US20020000814 Methods and apparatus for measuring electrical changes in neoplasms and foodborne pathogens in a liquid medium |
| 01/03/2002 | US20020000526 Yarn sensor |
| 01/03/2002 | US20020000398 Magnetic particles and methods of producing coated magnetic particles |
| 01/03/2002 | US20020000226 Automated carbon efflux system |
| 01/03/2002 | US20020000186 Evaluation method for polycrystalline silicon |
| 01/03/2002 | US20020000115 Odor measuring apparatus |
| 01/03/2002 | US20020000013 Stack of slides or film chips, easy removal |
| 01/03/2002 | DE10030854A1 Verfahren zur Ermittlung und/oder Erfassung des aktuellen Zustandes eines Schmiermittels Procedures for identifying and / or capture the current state of a lubricant |
| 01/03/2002 | DE10030728A1 Method for measuring the electro-kinetically produced mass flow and values derived from it in solid bodies, especially building material core samples, with a reaction gas escape route so measurements are not falsified |
| 01/03/2002 | DE10029915A1 Verfahren zum Nachweis von Cytosin-Methylierungen A method for the detection of cytosine methylations |
| 01/03/2002 | DE10029496A1 Determining specificity and activity of human T cells, useful e.g. for diagnosing infections, comprises enzyme-linked immunospot assay with the antigen provided as peptide library |
| 01/03/2002 | DE10028692A1 Verfahren zur Untersuchung von membranumschlossenen Biokompartimenten A method for investigating membrane-enclosed biocompartments |
| 01/03/2002 | CA2417699A1 Helicobacter pylori heptosyl transferase polypeptides |
| 01/03/2002 | CA2417692A1 Helicobacter dd-heptosyltransferase |
| 01/03/2002 | CA2414529A1 Ingestibles possessing intrinsic color change |
| 01/03/2002 | CA2414308A1 Transport peptides derived from erns protein, cytotoxic rnase of ribosome-inactivating protein or a rsv g-protein and analogues thereof |
| 01/03/2002 | CA2414295A1 Non-thermosensitive medium for analysing species inside a channel |
| 01/03/2002 | CA2414089A1 Improvements in and relating to chromophores |
| 01/03/2002 | CA2413940A1 Device and method for pneumatic gas sampling for gas sensors |
| 01/03/2002 | CA2413932A1 Interaction of colloid-immobilized species with species on non-colloidal structures |
| 01/03/2002 | CA2413884A1 Rapid and sensitive detection of protein aggregation |
| 01/03/2002 | CA2413747A1 Mammal 2p domain mechano-sensitive k+ channel, cloning and applications thereof |
| 01/03/2002 | CA2413742A1 Prion-binding activity in serum and proteins |
| 01/03/2002 | CA2413673A1 Thymic stromal lymphopoietin receptor molecules and uses thereof |
| 01/03/2002 | CA2413596A1 Cell lines and cell-based assays for identification of androgen receptor modulators |
| 01/03/2002 | CA2413547A1 B7-like molecules and uses thereof |
| 01/03/2002 | CA2413417A1 Selective androgen receptor modulators and methods for their identification, design and use |
| 01/03/2002 | CA2413354A1 Neurotoxic a.beta. oligomers in alzheimer's disease |
| 01/03/2002 | CA2413205A1 Glucose metering system |
| 01/03/2002 | CA2412721A1 Methods and compositions for transcription-based nucleic acid amplification |
| 01/03/2002 | CA2412635A1 Novel proteases |
| 01/03/2002 | CA2412612A1 Eg-vegf nucleic acids and polypeptides and methods of use |
| 01/03/2002 | CA2412610A1 Gp286 nucleic acids and polypeptides |
| 01/03/2002 | CA2412256A1 Polynucleotides and polypeptides encoded thereby |
| 01/03/2002 | CA2412239A1 Cytokine receptor zcytor17 |